- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT03165552
An Educational Intervention to Prevent Acute Kidney Injury in Primary Care. The ED-AKI-P Implementation Study (ED-AKI-P)
24 septembre 2019 mis à jour par: University of Leicester
Patients with abnormal kidney function are common in primary care, particularly in people with other long standing illnesses.
Some of these patients have long standing weakness of their kidneys, others develop new kidney weakness alongside other new illnesses.
Patients with weak kidneys are more likely to be admitted to hospital, spend longer in hospital or die than those with normal kidneys.
Although these events are common, how kidney weakness develops in the community is not well understood and awareness is poor.
It is known that appropriate attention to a patient's medical care at times of high risk may reduce the onset of new kidney weakness.
We have developed a new education package for primary healthcare professionals and patients.
This will teach them about risks of new kidney weakness in their patients, give advice about how to combat them, and help prevent it occurring.
This project will also use a new software tool - IMPAKT EVOLVE-AKI - to extract information from primary care systems and combine this with hospital data to identify developing kidney weakness much more accurately primary care .
Both these elements of the study have already been tested in primary care and we are confident that they work well.
Patients and the public have been involved in the development of these tools and will also be closely involved in their implementation.
We now intend to implement the education more widely in primary care.
We will then test how effectively the education has been implemented and whether it has a significant effect on the number of episodes of new kidney weakness developing in primary care.
We calculate that we will need to provide this education to 36 practices to be able to determine accurately whether the programme significantly reduces new kidney weakness.
Advice we have received from colleagues in primary care indicates that they are very interested in this education programme, and we believe that that a positive result from this study will lead to rapid and wide implementation of this combined programme of education and data analysis to the benefit of patients across the UK.
This study fits well with a national programme of work in this area, and this combination will help with wider adoption of the study findings when the results are available.
Aperçu de l'étude
Statut
Complété
Les conditions
Intervention / Traitement
Description détaillée
Acute kidney injury (AKI) is a common cause of excess morbidity and mortality amongst patients with long term conditions, and is a common finding in patients admitted acutely into hospital.
Although the disease commonly develops in the community there is little evidence to guide identification of patients at risk or how best to educate healthcare workers in primary care to improve the care of patients at risk of AKI.
We hypothesise firstly that: an AKI educational intervention in primary care can be delivered to healthcare practitioners with high integrity, and secondly that: an AKI educational intervention delivered in primary care will result in a decreased incidence of AKI in the community.
To test this we will build on pilot work that detects high-AKI risk patients and provides education for healthcare workers and at-risk patients.
The study will bring together novel informatics, and education programme for primary healthcare workers along with patient information and guidance.
Recruitment will be at the practice level and will take place after the delivery of the face to face educational intervention.
Recruited practices will have their high risk AKI patients identified using web based software, and GPs will be encouraged, where clinically appropriate, to contact patients with an educational leaflet advising them how to prevent AKI by stopping medications under certain circumstances.
In addition a variety of associated biomedical data will be obtained from practice IT systems to identify the preceding incidence of AKI in any recruited practice.
Eighteen months after the delivery of the education intervention the incidence of AKI in each practice will again be determined to examine the effect of the educational intervention on AKI incidence.
The fidelity of delivery of the education intervention will also be studied using qualitative techniques.
Power calculations suggest that 36 practices will need to participate to detect a 25% reduction in AKI incidence.
We anticipate that this programme will effectively reduce AKI community incidence and will be of significant interest to commissioners.
Study findings will be disseminated through a variety of avenues including through structures established by NHS England to support improvements in AKI management.
Type d'étude
Interventionnel
Inscription (Réel)
28
Phase
- N'est pas applicable
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
18 ans et plus (Adulte, Adulte plus âgé)
Accepte les volontaires sains
Non
Sexes éligibles pour l'étude
Tout
La description
Inclusion criteria:
All patients aged over 18 registered with the practice
Exclusion criteria:
Patients under the age of 18
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Recherche sur les services de santé
- Répartition: N / A
- Modèle interventionnel: Affectation à un seul groupe
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Educational Arm
This group will receive an acute kidney injury educational intervention
|
A face to face, a constructivist learning approach to encourage users to explore and learn about the topic of AKI in a way that maximises educational value.
The programme is supported by a web based resource that presents a series of realistic case studies highlighting common causes of AKI in primary care designed to be easy to access and navigate, whilst being visual and interactive to enhance user engagement.
The educayion is delivered to healthcare staff not to patients.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Incidence of acute kidney injury before and after educational intervention
Délai: 18 months
|
The incidence of AKI in a group of practices will be measured before and after an educational intervention
|
18 months
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Parrainer
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude (Réel)
1 novembre 2015
Achèvement primaire (Réel)
1 octobre 2018
Achèvement de l'étude (Réel)
1 octobre 2018
Dates d'inscription aux études
Première soumission
23 mai 2017
Première soumission répondant aux critères de contrôle qualité
23 mai 2017
Première publication (Réel)
24 mai 2017
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
26 septembre 2019
Dernière mise à jour soumise répondant aux critères de contrôle qualité
24 septembre 2019
Dernière vérification
1 septembre 2019
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 0524
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Lésion rénale aiguë
-
Zhen LiInscription sur invitationTransplantation simultanée Pancreas-KidneyChine
-
University Hospital, Basel, SwitzerlandPas encore de recrutementSyndrome cardiovasculaire-kidney-métabolique | Cradiovascular-Kidney-Liver-Metabolic (CKLM) SyndromeSuisse
-
Chung Shan Medical UniversityNational Science and Technology Council, TaiwanPas encore de recrutementObésité Diabète de type 2 | Maladie hépatique stéatosique associée à un dysfonctionnement métabolique | Syndrome cardiovasculaire-kidney-métaboliqueTaïwan
-
CHU de ReimsPas encore de recrutementRéactivité des fluides au début de la période de transplantation après le kidneyFrance
-
Camille N. Kotton, MDKamada, Ltd.; University of Texas Southwestern Medical CenterRecrutementCytomégalovirus | Greffe du rein; Complications | Greffe d'organe | Complantation du foie | Transplantation simultanée du foie-kidney; ComplicationsÉtats-Unis
-
Nanjing Medical UniversityPas encore de recrutementSyndrome cardiovasculaire-kidney-métabolique
-
First Affiliated Hospital of Fujian Medical UniversityRecrutementMaladies métaboliques | Maladie rénale chronique | Maladies cardiovasculaires (MCV) | Syndrome cardiovasculaire-kidney-métaboliqueChine
-
Kessler FoundationInstituto Vocacional Enrique Díaz de León A.C., Guadalajara, MexicoRecrutementTBI (Traumatic Brain Injury) ou MS (Sclérose en Plaques)États-Unis, Espagne
-
Chung Shan Medical UniversityNational Science and Technology Council, TaiwanComplétéDiabète de type 2 | Maladie du rein | Obésité et surpoids | Facteur de risque de maladie cardiovasculaire | Syndrome cardiovasculaire-kidney-métabolique
-
University of Alabama at BirminghamOhio State University; American Heart Association; Tuskegee UniversityRecrutementMaladies cardiovasculaires | Fumeur | Hypertension | Obésité | Diabète | Hyperlipidémie | Maladie du rein | Syndrome cardiovasculaire-kidney-métaboliqueÉtats-Unis